John P. Maufort

683 citations
12 papers · 487 indexed · h-index 8
Topics
Pluripotent Stem Cells Research (7 papers)CRISPR and Genetic Engineering (3 papers)Tissue Engineering and Regenerative Medicine (3 papers)
Partner nations
United StatesAustralia

In The Last Decade

John P. Maufort

12 papers receiving 479 citations

Peers

John P. Maufort
Comparison fields: 5 of 63
  • Molecular Biology 271
  • Epidemiology 119
  • Genetics 100
  • Immunology 100
  • Oncology 88
Replace Anastasia Conti with:
Anastasia Conti Italy
Arnaud Depaux France
Masaki Shirakata Japan
Irene Gil-Fariña Germany
Julita Ramírez United States
Evangelos Pefanis United States
Erik W. Martin United States
Bret Duffin United States
Agnieszka Bernat Poland
Mónica Martínez‐Moreno Spain
John P. Maufort relative to Anastasia Conti Italy Anastasia Conti's profile →
Citations per field
00.5×1.5×2.5×
Anastasia Conti · 1×
Citations per year

Countries citing papers authored by John P. Maufort

Since Specialization
Citations

This map shows the geographic impact of John P. Maufort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Maufort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Maufort more than expected).

Fields of papers citing papers by John P. Maufort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Maufort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Maufort. The network helps show where John P. Maufort may publish in the future.

Co-authorship network of co-authors of John P. Maufort

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Maufort. A scholar is included among the top collaborators of John P. Maufort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Maufort. John P. Maufort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 4
3 8
4 5
5 7
6 25
7 73
8 159
9 38
10 83
11 54
12 30

About John P. Maufort

John P. Maufort is a scholar working on Business and International Management, Virology and Molecular Biology, having authored 12 papers that have together received 487 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (3 papers) and Tissue Engineering and Regenerative Medicine (3 papers). The work is most often cited by research in Hematology (58 citations), Immunology (100 citations) and Molecular Biology (271 citations). John P. Maufort has collaborated with scholars based in United States and Australia. Frequent co-authors include James A. Thomson, Bret Duffin, Henry C. Pitot, Paul F. Lambert, Igor I. Slukvin, Brian E. McIntosh, David Vereide, Matthew E. Brown, Anny Shai and Sybil M. Genther Williams. Their work appears in journals such as PLoS ONE, Cancer Research and Chemical Research in Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026